Nutritional Interventional in Pediatric Patients With Osteogenesis Imperfecta
Calcium Intake Improvement After Nutritional Intervention in Pediatric Patients With Osteogenesis Imperfecta
1 other identifier
interventional
52
1 country
1
Brief Summary
BACKGROUND: In several bone disorders, adequate calcium intake is a coadjuvant intervention to regular treatment. Osteogenesis imperfecta (OI) is a collagen disorder with a range of symptoms, ranging from fractures to minimum trauma, and is typically treated with bisphosphonates. This study aims evaluate the impact of a nutritional intervention (NI) on dietary calcium intake, bone mineral density (BMD)in pediatric patients with OI. METHODS: Interventional cohort study was designed with a NI. Dietary calcium intake, anthropometry and clinical feature was assessed at baseline including anthropometry, basal metabolic rate (BMR), BMD, Food guidance form was developed and sent to patients by mail. After 12 months, patients' clinical features were reassessed and compared with baseline data. RESULTS: Fifty-two children and adolescents were enrolled. A significant increase in total calcium intake (g), the percentage of adequate calcium intake (%), number of cups of milk ingested, were observed after NI. Was detected a positive correlation between the variation of BMD and milk consumption in patients treated with bisphosphonate. CONCLUSION: Was observed an increase in calcium intake in patients with OI. This finding demonstrates the importance of nutrition therapy as part of a multidisciplinary treatment approach for bone health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2014
CompletedFirst Submitted
Initial submission to the registry
February 13, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedFebruary 19, 2019
January 1, 2019
1.3 years
February 13, 2019
February 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Calcium intake
Was assessed using an food frequency questionaire adapted to calcium intake
12 months
Secondary Outcomes (3)
Consumption of glasses of milk
12 months
Body mass index
12 months
Bone Mineral Density
12 months
Study Arms (1)
Nutritional Orientation
OTHERThe patients received a nutritional orientation with emphasis in food rich in calcium
Interventions
Nutritional orientation with emphasis in rich calcium food
Eligibility Criteria
You may qualify if:
- Patients from zero to 19 years of patients seen at hospital.
- Diagnosed with osteogenesis imperfecta
You may not qualify if:
- \- Diagnosed with bone disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-007, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elza D Mello, MD, PhD
Hospital de Clinicas de Porto Alegre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2019
First Posted
February 15, 2019
Study Start
February 8, 2012
Primary Completion
May 20, 2013
Study Completion
February 10, 2014
Last Updated
February 19, 2019
Record last verified: 2019-01